Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Weidinger

Showing results (121-130 of 274) with videos related to

Pageof 28
Sort By:
Journal of the American Academy of Dermatology|December 6, 2022
Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trialLisa A Beck, Thomas Bieber, Stephan Weidinger, et al.
The British Journal of Dermatology|December 10, 2024
Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitisStephan Weidinger, Anthony Bewley, H Chih-Ho Hong, et al.
The Journal of Investigative Dermatology|September 15, 2022
Quantitative Proteomics Identifies Reduced NRF2 Activity and Mitochondrial Dysfunction in Atopic DermatitisMichael Koch, Tobias Kockmann, Elke Rodriguez, et al.
Acta Dermato-Venereologica|May 29, 2023
Effects of Early Emollient Use in Children at High Risk of Atopic Dermatitis: A German Pilot StudyInken Harder, Dora Stölzl, Nicole Sander, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 1, 2017
Einsatz und Wirksamkeit von Systemtherapien bei Erwachsenen mit schwerer Neurodermitis: Erste Ergebnisse des deutschen Neurodermitis-Registers TREATgermanyJochen Schmitt, Susanne Abraham, Freya Trautmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 19, 2016
Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermanyJochen Schmitt, Susanne Abraham, Freya Trautmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 30, 2024
Detecting T-cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumabHyungdon Kook, Ho Eun Gwag, So Yun Park, et al.
Nature Genetics|October 26, 2023
Effects of psoriasis and psoralen exposure on the somatic mutation landscape of the skinSigurgeir Olafsson, Elke Rodriguez, Andrew R J Lawson, et al.
The Journal of Investigative Dermatology|August 24, 2025
Endothelin-2 from keratinocytes and Its Association with Itch in Skin DiseasesYumeng Dong, Mrinal K Sarkar, Yuntian Wu, et al.
The British Journal of Dermatology|March 26, 2024
Blockade of interleukin-13 signalling improves skin barrier function and biology in patients with moderate-to-severe atopic dermatitisNicole Sander, Dora Stölzl, Melina Fonfara, et al.
Pageof 28

Showing results (121-130 of 274) with videos related to

Sort By:
Pageof 28
Journal of the American Academy of Dermatology|December 6, 2022
Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trialLisa A Beck, Thomas Bieber, Stephan Weidinger, et al.
The British Journal of Dermatology|December 10, 2024
Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitisStephan Weidinger, Anthony Bewley, H Chih-Ho Hong, et al.
The Journal of Investigative Dermatology|September 15, 2022
Quantitative Proteomics Identifies Reduced NRF2 Activity and Mitochondrial Dysfunction in Atopic DermatitisMichael Koch, Tobias Kockmann, Elke Rodriguez, et al.
Acta Dermato-Venereologica|May 29, 2023
Effects of Early Emollient Use in Children at High Risk of Atopic Dermatitis: A German Pilot StudyInken Harder, Dora Stölzl, Nicole Sander, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 1, 2017
Einsatz und Wirksamkeit von Systemtherapien bei Erwachsenen mit schwerer Neurodermitis: Erste Ergebnisse des deutschen Neurodermitis-Registers TREATgermanyJochen Schmitt, Susanne Abraham, Freya Trautmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 19, 2016
Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermanyJochen Schmitt, Susanne Abraham, Freya Trautmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 30, 2024
Detecting T-cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumabHyungdon Kook, Ho Eun Gwag, So Yun Park, et al.
Nature Genetics|October 26, 2023
Effects of psoriasis and psoralen exposure on the somatic mutation landscape of the skinSigurgeir Olafsson, Elke Rodriguez, Andrew R J Lawson, et al.
The Journal of Investigative Dermatology|August 24, 2025
Endothelin-2 from keratinocytes and Its Association with Itch in Skin DiseasesYumeng Dong, Mrinal K Sarkar, Yuntian Wu, et al.
The British Journal of Dermatology|March 26, 2024
Blockade of interleukin-13 signalling improves skin barrier function and biology in patients with moderate-to-severe atopic dermatitisNicole Sander, Dora Stölzl, Melina Fonfara, et al.
Pageof 28